Alternative Medicine Times: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Alternative Medicine Times.

Press releases published on June 8, 2026

Jun. 8, 2026

First USDA Organic Texas-Exclusive Dog Treat Debuts at Leading Texas Retailer Partner

Indeterminate GlobeNewswire

Jun. 8, 2026

Capricor Therapeutics to Present at Upcoming Investor Conferences

Indeterminate GlobeNewswire

Jun. 8, 2026

Polyrizon Makes Strong Clinical Progress: Secures Three U.S. Sites for NASARIX™ Trial

Indeterminate GlobeNewswire

Jun. 8, 2026

Healthcare Financial Management Association recognizes Dennis Dahlen for contributions to healthcare

Indeterminate GlobeNewswire

Jun. 8, 2026

TOMI Environmental Targets Drone-Enabled SteraMist® Technology for High-Growth AI, Autonomous Robotics and Biosecurity Markets

Indeterminate GlobeNewswire

Jun. 8, 2026

Healthcare Financial Management Association (HFMA) announces Matthew E. Cox as National Chair along with new officers, board members

Indeterminate GlobeNewswire

Jun. 8, 2026

These New Spa Treatments at Benchmark Resorts & Hotels Remove 25 Pounds of Plastic and Trash from the Ocean in 50 Minutes

Indeterminate GlobeNewswire

Jun. 8, 2026

EnWave Signs Technology Evaluation and License Option Agreement with Swiss Cannabis Selection AG, Announces Significant Evaluation Results

Indeterminate GlobeNewswire

Jun. 8, 2026

National Action Urged to Address Chronic Pain Crisis Among Women and Women Veterans in Canada

Indeterminate GlobeNewswire

Jun. 8, 2026

Appel À Une Action Nationale Pour Lutter Contre La Crise De La Douleur Chronique Chez Les Femmes Et Les Vétéranes Au Canada

Indeterminate GlobeNewswire

Jun. 8, 2026

Sharecare to honor extraordinary nurses through The DAISY Foundation’s global recognition program

Indeterminate GlobeNewswire

Jun. 8, 2026

Numerator Consumer Goods Price Index Reveals Highest Inflation in Over Two Years, With Prices Up 2.9%

Indeterminate GlobeNewswire

Jun. 8, 2026

ADARx Pharmaceuticals to Present Onvuzosiran (ADX-324) Phase 1/2 Clinical Data Supporting the Ongoing Phase 3 STOP-HAE Clinical Trial at the 2026 Annual EAACI Congress

Indeterminate GlobeNewswire

Jun. 8, 2026

Fat Brain Toys Introduces Viral UK Puzzle Line “Can You Solve Me?” to U.S. Retailers

Indeterminate GlobeNewswire

Jun. 8, 2026

ViVi Youth Launches Advanced Myo-Inositol & D-Chiro Inositol Formula Designed for Women’s Daily Wellness Support

Indeterminate GlobeNewswire

Jun. 8, 2026

Alkeus Pharmaceuticals Announces First Patient Dosed in Pivotal Global Phase 3 NORTHSTAR Study of Oral Gildeuretinol in Stargardt Disease

Indeterminate GlobeNewswire

Jun. 8, 2026

Ambros Therapeutics Announces First Patient Dosed in Pivotal CRPS-RISE Phase 3 Clinical Trial of Neridronate in Patients with Complex Regional Pain Syndrome Type 1

Indeterminate GlobeNewswire

Jun. 8, 2026

AIM ImmunoTech Reports Positive Mid-Year Interim Clinical Progress from Phase 2 Study Evaluating Ampligen® (rintatolimod) in Combination with AstraZeneca’s Imfinzi® (durvalumab) for the Treatment of Pancreatic Cancer

Indeterminate GlobeNewswire

Jun. 8, 2026

Telitacicept Receives NMPA Approval for the Treatment of Sjögren’s Disease in China

Indeterminate GlobeNewswire

Jun. 8, 2026

Medera Expands Scientific Advisory Board with Leading Heart Failure and Cardiopulmonary Physiology Experts to Advance HFpEF Gene Therapy Program

Indeterminate GlobeNewswire